Skip to main
  1. Stocks
  2. UnitedHealth Group
  3. Forecast
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 25%
Buy 60%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is supported by massive scale in medical benefits and a diversified Optum platform that spans pharmacy benefits, outpatient care, and analytics, giving it broad exposure across the U.S. healthcare continuum and improving earnings visibility. Its 3Q26 adjusted EPS of $4.69 beat consensus, MCR was better than expected, and management lifted 2026 adjusted EPS guidance to at least $20.50, while Medicare Advantage margins are trending near the top of the 2% to 4% range and Medicaid appears to be at or near a trough. The bullish case also rests on durable OptumHealth execution, external growth at Optum Rx, and strong cash flow with a solid balance sheet, all of which support margin expansion, disciplined pricing, and continued double-digit long-term earnings growth.

Bears say

UnitedHealth Group is facing a deteriorating fundamental backdrop as accelerating Medicare Advantage utilization, commercial medical-cost pressure, and weak visibility into near-term MLR trends threaten earnings quality and margin stability. The downside case assumes FY28 EPS about 10% below base case and a lower 15.0x multiple, reflecting risks from network contracting, reimbursement pressure in the government business, and regulatory scrutiny that could hit MA, PBM, and Medicaid profitability. Continued IDR, specialty-drug, and provider coding-intensity inflation, along with potential CMS reimbursement cuts and increased MA competition, further cloud the earnings path and justify a cautious stance.

UnitedHealth Group (UNH) has been analyzed by 20 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 60% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

UnitedHealth Group (UNH) Analyst Forecast & Price Prediction

Get the latest UnitedHealth Group (UNH) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in UnitedHealth Group (UNH)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 20 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $461.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $461.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


UnitedHealth Group (UNH) Analyst Forecast & Price Prediction

Get the latest UnitedHealth Group (UNH) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in UnitedHealth Group (UNH)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover UNH stock data and trends